• Profile
Close

Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: A 24-week follow-up study

International Clinical Psychopharmacology Jan 18, 2018

Chia-Hsiang C, et al. - The effectiveness of aripiprazole was examined in psychotic patients with a pre-existing tardive dyskinesia (TD). Researchers revealed that in psychotic patients with TD, aripiprazole could be a promising treatment for clinicians considering drug switch.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay